Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
10.9M
-
Number of holders
-
240
-
Total 13F shares, excl. options
-
11.3M
-
Shares change
-
+377K
-
Total reported value, excl. options
-
$1.42B
-
Value change
-
+$13.2M
-
Put/Call ratio
-
0.91
-
Number of buys
-
126
-
Number of sells
-
-140
-
Price
-
$125.02
Significant Holders of MEDIFAST INC - Common Stock, $0.001 par value per share (MED) as of Q4 2018
318 filings reported holding MED - MEDIFAST INC - Common Stock, $0.001 par value per share as of Q4 2018.
MEDIFAST INC - Common Stock, $0.001 par value per share (MED) has 240 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.3M shares
.
Largest 10 shareholders include BlackRock Inc. (1.7M shares), Vanguard Group Inc (1.38M shares), RENAISSANCE TECHNOLOGIES LLC (990K shares), DIMENSIONAL FUND ADVISORS LP (659K shares), ACADIAN ASSET MANAGEMENT LLC (433K shares), STATE STREET CORP (379K shares), MERIAN GLOBAL INVESTORS (UK) Ltd (304K shares), PRINCIPAL FINANCIAL GROUP INC (215K shares), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (207K shares), and Bank of New York Mellon Corp (195K shares).
This table shows the top 240 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.